Efficacy, Safety, and Pharmacokinetics of Golimumab in Children with Moderately-To-Severely Active Ulcerative Colitis: Results from the PURSUIT 2 Study
- Dan Turner
- , Kathleen G. Lomax*
- , Gigi Veereman
- , Anne M. Griffiths
- , Jaroslaw Kierkuś
- , Ben Kang
- , Katherine Berezny
- , Lakshmi Padgett
- , Gary Mao
- , Yevgeny Zitser
- , Richard S. Strauss
- , Jeroen Verhoeven
- , Omoniyi J. Adedokun
- , Jeffrey S. Hyams
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
2
Scopus
citations